BioHarvest Sciences Inc. Common Stock
BHST
About: BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Employees: 87
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 8 [Q1] → 8 (+0) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.09% less ownership
Funds ownership: 0.74% [Q1] → 0.66% (-0.09%) [Q2]
10% less capital invested
Capital invested by funds: $803K [Q1] → $724K (-$78.2K) [Q2]
Financial journalist opinion
Based on 4 articles about BHST published over the past 30 days
